# REGORAFENIB
> **ANDA209728** · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL · Approved 2025-01-13
## Drug
- **FDA Application Number:** ANDA209728
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** REGORAFENIB
- **Generic name:** Regorafenib
- **Active ingredients:** REGORAFENIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ACTAVIS LABS FL
- **First approval:** 2025-01-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209728)
---
*AI Analytics · CC0 1.0*